Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v5-EN
Language French English
Date Updated 2019-11-22 2019-07-07
Drug Identification Number 02329751 02329751
Brand name DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP DIAGNOSTIC DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP DIAGNOSTIC
Common or Proper name Sodium Iodide 131 Sodium Iodide 131
Company Name JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
Ingredients SODIUM IODIDE 131 I SODIUM IODIDE 131 I
Strength(s) 3.7MBq 3.7MBq
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 5 Capsules/Vial 5 Capsules/Vial
ATC code V09FX V09FX
ATC description
Reason for shortage Other (Please describe in comments) Shortage of an active ingredient.
Anticipated start date 2019-07-06 2019-07-06
Actual start date
Estimated end date Unknown 2019-07-11
Actual end date 2019-07-19
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Awating release of a component
Health Canada comments